ClinicalTrials.Veeva

Menu

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE)

ResMed logo

ResMed

Status

Withdrawn

Conditions

Central Sleep Apnea
Heart Failure

Treatments

Other: telemonitoring

Study type

Observational

Funder types

Industry

Identifiers

NCT02356367
Face Pilot Study

Details and patient eligibility

About

The purpose of this study is to determine the predictive factors of poor compliance to sleep disordered breathing therapy in chronic heart failure patients treated for central sleep apnea. To characterize nocturia pathophysiology associated with SDB in this population. To use telemonitoring data to define predictive factors of poor compliance.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult Patient with Chronic Heart Failure
  • Central Sleep Apnea requiring Adaptative Servo-Ventilation therapy
  • Patient is able to fully understand study information and signed informed consent

Exclusion criteria

  • Contra-indications to Adaptative Servo-Ventilation therapy
  • Respiratory Failure or Hypercapnia inconsistent with Adaptative Servo-Ventilation therapy

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems